title: Inhibition of phenylephrine-induced cardiomyocyte hypertrophy by activation of multiple adenosine receptor subtypes.
authors.affiliation: Department of Physiology and Pharmacology, University of Western Ontario, Medical Sciences Building, London, Ontario N6A 5C1, Canada.
authors.forename: Xiaohong Tracey
authors.initials: XT
authors.lastname: Gan
authors.forename: Venkatesh
authors.initials: V
authors.lastname: Rajapurohitam
authors.forename: James V
authors.initials: JV
authors.lastname: Haist
authors.forename: Peter
authors.initials: P
authors.lastname: Chidiac
authors.forename: Michael A
authors.initials: MA
authors.lastname: Cook
authors.forename: Morris
authors.initials: M
authors.lastname: Karmazyn
mesh_terms: D000241:Adenosine / Q000031:analogs & derivatives* / Q000494:pharmacology; D058907:Adenosine A1 Receptor Agonists; D058908:Adenosine A2 Receptor Agonists; D058909:Adenosine A3 Receptor Agonists; D000316:Adrenergic alpha-Agonists / Q000009:adverse effects; D000818:Animals; D004347:Drug Interactions; D006984:Hypertrophy / Q000139:chemically induced*; D032383:Myocytes, Cardiac / Q000187:drug effects*; D010627:Phenethylamines / Q000494:pharmacology; D010656:Phenylephrine / Q000009:adverse effects* / Q000037:antagonists & inhibitors; D051381:Rats; D017207:Rats, Sprague-Dawley; D043682:Receptor, Adenosine A1 / Q000502:physiology*; D043705:Receptor, Adenosine A2A / Q000502:physiology*; D043684:Receptor, Adenosine A3 / Q000502:physiology*
chemical_list: D058907:Adenosine A1 Receptor Agonists; D058908:Adenosine A2 Receptor Agonists; D058909:Adenosine A3 Receptor Agonists; D000316:Adrenergic alpha-Agonists; D010627:Phenethylamines; D043682:Receptor, Adenosine A1; D043705:Receptor, Adenosine A2A; D043684:Receptor, Adenosine A3; C061282:2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine; C084956:N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine; D010656:Phenylephrine; C048599:N(6)-cyclopentyladenosine; D000241:Adenosine